Regensburg, Germany
NeoPredics AG, founded in 2020, is a promising player in the Health Care and Medical Devices sectors. Headquartered in Germany, the company is focused on enhancing and personalizing healthcare, particularly for maternal and neonatal care. Their mission is encapsulated in their slogan, "Enhance & Personalize Healthcare in Maternal and Neonatal Care."
NeoPredics AG specializes in intelligent digital health solutions that streamline decision-making in clinical practice. By doing so, they aim to positively impact the lives of children and their families, minimize unnecessary hospital stays, and ultimately reduce healthcare costs.
Their innovative approach has captured the attention of investors, as evidenced by a €4.10M Series A investment on March 17, 2021. Key investors include Bayern Kapital, Eckenstein-Geigy Stiftung, and LifeCare Partners. This strong financial backing underscores NeoPredics AG's potential to drive significant advances in digital health solutions.
